Loading…

Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models

[Display omitted] •β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line. Synthesis of β-amino acid derivatives co...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic chemistry 2021-10, Vol.115, p.105214-105214, Article 105214
Main Authors: Žukauskas, Mindaugas, Grybaitė, Birutė, Jonutė, Paulina, Vaickelionienė, Rita, Gibieža, Paulius, Vaickelionis, Giedrius, Dragūnaitė, Bertina, Anusevičius, Kazimieras, Mickevičius, Vytautas, Petrikaitė, Vilma
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383
cites cdi_FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383
container_end_page 105214
container_issue
container_start_page 105214
container_title Bioorganic chemistry
container_volume 115
creator Žukauskas, Mindaugas
Grybaitė, Birutė
Jonutė, Paulina
Vaickelionienė, Rita
Gibieža, Paulius
Vaickelionis, Giedrius
Dragūnaitė, Bertina
Anusevičius, Kazimieras
Mickevičius, Vytautas
Petrikaitė, Vilma
description [Display omitted] •β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line. Synthesis of β-amino acid derivatives containing hydrazone and azole moieties is described. For this purpose, the appropriate hydrazide was treated with aromatic aldehydes, ketones and phenyl iso(thio)cyanates to obtain the desired outcome. The synthesized target compounds were evaluated for their anticancer properties. The assay displayed 3,3′-((2,6-diethylphenyl)azanediyl)bis(N′-(benzylidene)propanehydrazide) to possess the convincing anticancer effect against triple-negative breast cancer cells in vitro. To further study the anticancer properties of compounds containing a hydrazone moiety in breast cancer, series of previously and newly prepared dihydrazones were investigated. It was determined that derivatives with the bis(N′-(4-bromobenzylidene) fragment in the structure are exclusively cytotoxic to cancer cells. The most active compounds against both cell lines were those containing electron withdrawing 4-BrPh or 4-ClPh moieties, together with either chlorine, bromine or iodine groups in para position of phenyl ring. Selected two representative compounds showed migrastatic activity in MDA-MB-231 cell line, where both of them reduced the growth of breast cancer and glioblastoma cell 3D cultures and inhibited cell colony formation. 2009 Elsevier Ltd. All rights reserved.
doi_str_mv 10.1016/j.bioorg.2021.105214
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2564131959</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0045206821005915</els_id><sourcerecordid>2564131959</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383</originalsourceid><addsrcrecordid>eNp9kM-KFDEQh4Mo7rj6BiI5esmYSqfTnYsgy_oHFr3oOaTT1UOGdDImPQ1efSQfxGcyY-96FAIFVd8vRX2EvAS-Bw7qzXE_-JTyYS-4gNpqBchHZAdccyZA8Mdkx7lsmeCqvyLPSjlyDiA79ZRcNVIKBQp25OftasPZLj5Fmib6mdn8I7Dfv5gNNvqIdMTs1zpfsVBbX1y8s9FhpvaAcSnUR7pkfwrIIh7-gnTIaMtCH7g40kPwaQi1mWZ7Sax-yYnOacRQnpMnkw0FX9zXa_Lt_e3Xm4_s7suHTzfv7phrlFiY6waFoMdWCC25VrqdoOUgpey7RmKPGrrOgu6bOtGi75zkXdtMuqmtoemba_J6-_eU0_czlsXMvjgM9VBM52JEqyQ0oFtdUbmhLqdSMk7mlP1c1Rjg5mLfHM1m31zsm81-jb2633AeZhz_hR50V-DtBtSzcfWYTXEeq6XRZ3SLGZP__4Y_KeaYQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2564131959</pqid></control><display><type>article</type><title>Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models</title><source>Elsevier</source><creator>Žukauskas, Mindaugas ; Grybaitė, Birutė ; Jonutė, Paulina ; Vaickelionienė, Rita ; Gibieža, Paulius ; Vaickelionis, Giedrius ; Dragūnaitė, Bertina ; Anusevičius, Kazimieras ; Mickevičius, Vytautas ; Petrikaitė, Vilma</creator><creatorcontrib>Žukauskas, Mindaugas ; Grybaitė, Birutė ; Jonutė, Paulina ; Vaickelionienė, Rita ; Gibieža, Paulius ; Vaickelionis, Giedrius ; Dragūnaitė, Bertina ; Anusevičius, Kazimieras ; Mickevičius, Vytautas ; Petrikaitė, Vilma</creatorcontrib><description>[Display omitted] •β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line. Synthesis of β-amino acid derivatives containing hydrazone and azole moieties is described. For this purpose, the appropriate hydrazide was treated with aromatic aldehydes, ketones and phenyl iso(thio)cyanates to obtain the desired outcome. The synthesized target compounds were evaluated for their anticancer properties. The assay displayed 3,3′-((2,6-diethylphenyl)azanediyl)bis(N′-(benzylidene)propanehydrazide) to possess the convincing anticancer effect against triple-negative breast cancer cells in vitro. To further study the anticancer properties of compounds containing a hydrazone moiety in breast cancer, series of previously and newly prepared dihydrazones were investigated. It was determined that derivatives with the bis(N′-(4-bromobenzylidene) fragment in the structure are exclusively cytotoxic to cancer cells. The most active compounds against both cell lines were those containing electron withdrawing 4-BrPh or 4-ClPh moieties, together with either chlorine, bromine or iodine groups in para position of phenyl ring. Selected two representative compounds showed migrastatic activity in MDA-MB-231 cell line, where both of them reduced the growth of breast cancer and glioblastoma cell 3D cultures and inhibited cell colony formation. 2009 Elsevier Ltd. All rights reserved.</description><identifier>ISSN: 0045-2068</identifier><identifier>EISSN: 1090-2120</identifier><identifier>DOI: 10.1016/j.bioorg.2021.105214</identifier><identifier>PMID: 34426161</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alanine - analogs &amp; derivatives ; Alanine - chemistry ; Alanine - pharmacology ; Anticancer activity ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Azoles ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Glioblastoma - drug therapy ; Glioblastoma - metabolism ; Glioblastoma - pathology ; Humans ; Hydrazones ; Molecular Structure ; Pyrrolidinones ; Structure-Activity Relationship ; Triple Negative Breast Neoplasms - drug therapy ; Triple Negative Breast Neoplasms - metabolism ; Triple Negative Breast Neoplasms - pathology ; β-Amino acids</subject><ispartof>Bioorganic chemistry, 2021-10, Vol.115, p.105214-105214, Article 105214</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383</citedby><cites>FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34426161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Žukauskas, Mindaugas</creatorcontrib><creatorcontrib>Grybaitė, Birutė</creatorcontrib><creatorcontrib>Jonutė, Paulina</creatorcontrib><creatorcontrib>Vaickelionienė, Rita</creatorcontrib><creatorcontrib>Gibieža, Paulius</creatorcontrib><creatorcontrib>Vaickelionis, Giedrius</creatorcontrib><creatorcontrib>Dragūnaitė, Bertina</creatorcontrib><creatorcontrib>Anusevičius, Kazimieras</creatorcontrib><creatorcontrib>Mickevičius, Vytautas</creatorcontrib><creatorcontrib>Petrikaitė, Vilma</creatorcontrib><title>Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models</title><title>Bioorganic chemistry</title><addtitle>Bioorg Chem</addtitle><description>[Display omitted] •β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line. Synthesis of β-amino acid derivatives containing hydrazone and azole moieties is described. For this purpose, the appropriate hydrazide was treated with aromatic aldehydes, ketones and phenyl iso(thio)cyanates to obtain the desired outcome. The synthesized target compounds were evaluated for their anticancer properties. The assay displayed 3,3′-((2,6-diethylphenyl)azanediyl)bis(N′-(benzylidene)propanehydrazide) to possess the convincing anticancer effect against triple-negative breast cancer cells in vitro. To further study the anticancer properties of compounds containing a hydrazone moiety in breast cancer, series of previously and newly prepared dihydrazones were investigated. It was determined that derivatives with the bis(N′-(4-bromobenzylidene) fragment in the structure are exclusively cytotoxic to cancer cells. The most active compounds against both cell lines were those containing electron withdrawing 4-BrPh or 4-ClPh moieties, together with either chlorine, bromine or iodine groups in para position of phenyl ring. Selected two representative compounds showed migrastatic activity in MDA-MB-231 cell line, where both of them reduced the growth of breast cancer and glioblastoma cell 3D cultures and inhibited cell colony formation. 2009 Elsevier Ltd. All rights reserved.</description><subject>Alanine - analogs &amp; derivatives</subject><subject>Alanine - chemistry</subject><subject>Alanine - pharmacology</subject><subject>Anticancer activity</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Azoles</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Glioblastoma - drug therapy</subject><subject>Glioblastoma - metabolism</subject><subject>Glioblastoma - pathology</subject><subject>Humans</subject><subject>Hydrazones</subject><subject>Molecular Structure</subject><subject>Pyrrolidinones</subject><subject>Structure-Activity Relationship</subject><subject>Triple Negative Breast Neoplasms - drug therapy</subject><subject>Triple Negative Breast Neoplasms - metabolism</subject><subject>Triple Negative Breast Neoplasms - pathology</subject><subject>β-Amino acids</subject><issn>0045-2068</issn><issn>1090-2120</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM-KFDEQh4Mo7rj6BiI5esmYSqfTnYsgy_oHFr3oOaTT1UOGdDImPQ1efSQfxGcyY-96FAIFVd8vRX2EvAS-Bw7qzXE_-JTyYS-4gNpqBchHZAdccyZA8Mdkx7lsmeCqvyLPSjlyDiA79ZRcNVIKBQp25OftasPZLj5Fmib6mdn8I7Dfv5gNNvqIdMTs1zpfsVBbX1y8s9FhpvaAcSnUR7pkfwrIIh7-gnTIaMtCH7g40kPwaQi1mWZ7Sax-yYnOacRQnpMnkw0FX9zXa_Lt_e3Xm4_s7suHTzfv7phrlFiY6waFoMdWCC25VrqdoOUgpey7RmKPGrrOgu6bOtGi75zkXdtMuqmtoemba_J6-_eU0_czlsXMvjgM9VBM52JEqyQ0oFtdUbmhLqdSMk7mlP1c1Rjg5mLfHM1m31zsm81-jb2633AeZhz_hR50V-DtBtSzcfWYTXEeq6XRZ3SLGZP__4Y_KeaYQw</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Žukauskas, Mindaugas</creator><creator>Grybaitė, Birutė</creator><creator>Jonutė, Paulina</creator><creator>Vaickelionienė, Rita</creator><creator>Gibieža, Paulius</creator><creator>Vaickelionis, Giedrius</creator><creator>Dragūnaitė, Bertina</creator><creator>Anusevičius, Kazimieras</creator><creator>Mickevičius, Vytautas</creator><creator>Petrikaitė, Vilma</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202110</creationdate><title>Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models</title><author>Žukauskas, Mindaugas ; Grybaitė, Birutė ; Jonutė, Paulina ; Vaickelionienė, Rita ; Gibieža, Paulius ; Vaickelionis, Giedrius ; Dragūnaitė, Bertina ; Anusevičius, Kazimieras ; Mickevičius, Vytautas ; Petrikaitė, Vilma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alanine - analogs &amp; derivatives</topic><topic>Alanine - chemistry</topic><topic>Alanine - pharmacology</topic><topic>Anticancer activity</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Azoles</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Glioblastoma - drug therapy</topic><topic>Glioblastoma - metabolism</topic><topic>Glioblastoma - pathology</topic><topic>Humans</topic><topic>Hydrazones</topic><topic>Molecular Structure</topic><topic>Pyrrolidinones</topic><topic>Structure-Activity Relationship</topic><topic>Triple Negative Breast Neoplasms - drug therapy</topic><topic>Triple Negative Breast Neoplasms - metabolism</topic><topic>Triple Negative Breast Neoplasms - pathology</topic><topic>β-Amino acids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Žukauskas, Mindaugas</creatorcontrib><creatorcontrib>Grybaitė, Birutė</creatorcontrib><creatorcontrib>Jonutė, Paulina</creatorcontrib><creatorcontrib>Vaickelionienė, Rita</creatorcontrib><creatorcontrib>Gibieža, Paulius</creatorcontrib><creatorcontrib>Vaickelionis, Giedrius</creatorcontrib><creatorcontrib>Dragūnaitė, Bertina</creatorcontrib><creatorcontrib>Anusevičius, Kazimieras</creatorcontrib><creatorcontrib>Mickevičius, Vytautas</creatorcontrib><creatorcontrib>Petrikaitė, Vilma</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Žukauskas, Mindaugas</au><au>Grybaitė, Birutė</au><au>Jonutė, Paulina</au><au>Vaickelionienė, Rita</au><au>Gibieža, Paulius</au><au>Vaickelionis, Giedrius</au><au>Dragūnaitė, Bertina</au><au>Anusevičius, Kazimieras</au><au>Mickevičius, Vytautas</au><au>Petrikaitė, Vilma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models</atitle><jtitle>Bioorganic chemistry</jtitle><addtitle>Bioorg Chem</addtitle><date>2021-10</date><risdate>2021</risdate><volume>115</volume><spage>105214</spage><epage>105214</epage><pages>105214-105214</pages><artnum>105214</artnum><issn>0045-2068</issn><eissn>1090-2120</eissn><abstract>[Display omitted] •β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line. Synthesis of β-amino acid derivatives containing hydrazone and azole moieties is described. For this purpose, the appropriate hydrazide was treated with aromatic aldehydes, ketones and phenyl iso(thio)cyanates to obtain the desired outcome. The synthesized target compounds were evaluated for their anticancer properties. The assay displayed 3,3′-((2,6-diethylphenyl)azanediyl)bis(N′-(benzylidene)propanehydrazide) to possess the convincing anticancer effect against triple-negative breast cancer cells in vitro. To further study the anticancer properties of compounds containing a hydrazone moiety in breast cancer, series of previously and newly prepared dihydrazones were investigated. It was determined that derivatives with the bis(N′-(4-bromobenzylidene) fragment in the structure are exclusively cytotoxic to cancer cells. The most active compounds against both cell lines were those containing electron withdrawing 4-BrPh or 4-ClPh moieties, together with either chlorine, bromine or iodine groups in para position of phenyl ring. Selected two representative compounds showed migrastatic activity in MDA-MB-231 cell line, where both of them reduced the growth of breast cancer and glioblastoma cell 3D cultures and inhibited cell colony formation. 2009 Elsevier Ltd. All rights reserved.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34426161</pmid><doi>10.1016/j.bioorg.2021.105214</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0045-2068
ispartof Bioorganic chemistry, 2021-10, Vol.115, p.105214-105214, Article 105214
issn 0045-2068
1090-2120
language eng
recordid cdi_proquest_miscellaneous_2564131959
source Elsevier
subjects Alanine - analogs & derivatives
Alanine - chemistry
Alanine - pharmacology
Anticancer activity
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Azoles
Cell Line, Tumor
Cell Proliferation - drug effects
Cell Survival - drug effects
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Glioblastoma - drug therapy
Glioblastoma - metabolism
Glioblastoma - pathology
Humans
Hydrazones
Molecular Structure
Pyrrolidinones
Structure-Activity Relationship
Triple Negative Breast Neoplasms - drug therapy
Triple Negative Breast Neoplasms - metabolism
Triple Negative Breast Neoplasms - pathology
β-Amino acids
title Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A22%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20N-aryl-%CE%B2-alanine%20derivatives%20as%20anticancer%20agents%20in%20triple-negative%20breast%20cancer%20and%20glioblastoma%20in%20vitro%20models&rft.jtitle=Bioorganic%20chemistry&rft.au=%C5%BDukauskas,%20Mindaugas&rft.date=2021-10&rft.volume=115&rft.spage=105214&rft.epage=105214&rft.pages=105214-105214&rft.artnum=105214&rft.issn=0045-2068&rft.eissn=1090-2120&rft_id=info:doi/10.1016/j.bioorg.2021.105214&rft_dat=%3Cproquest_cross%3E2564131959%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2564131959&rft_id=info:pmid/34426161&rfr_iscdi=true